Tirzepatide concentration in Mounjaro: what the numbers actually mean

What the concentration scale is actually asking you to decide

When you start Mounjaro, you are not choosing a final destination, you are choosing a starting point. The question your prescriber is framing at every review is: has your body settled well enough at this concentration to move up, or does it need more time here? That is the real decision the tirzepatide dose ladder is built around.

The six strengths exist because the body's response to a dual GIP and GLP-1 receptor agonist changes as the concentration rises. Early doses are calibrated to let your digestive system adjust; higher concentrations deliver progressively more of the appetite-regulating effect that the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed produces meaningful weight reduction over 72 weeks. At 15 mg, the highest concentration, trial participants achieved an average body-weight reduction of around 20–21%. That figure came from a population of thousands of adults; your result will depend on your own biology, your diet and activity, and how long you stay on treatment.

A useful tool for thinking through the numbers at each stage is the tirzepatide concentration calculator, which puts the dose steps in context. But the numbers only mean something once a prescriber has assessed whether a step up is appropriate for you specifically.

Why the 2.5 mg concentration is not the weak one

A common source of confusion is reading the 2.5 mg starting concentration as somehow less serious than the higher strengths. It is not. The starter dose exists to settle your system rather than to produce the full therapeutic effect. Nausea, the side effect people most often report early on, is strongly linked to how quickly the concentration rises; 2.5 mg gives the gut-slowing, appetite-signalling mechanism time to become familiar before the intensity increases.

The NHS medicines page for tirzepatide explains this titration principle clearly: treatment typically moves up through the concentrations in 4-week steps, guided by how well the previous dose was tolerated. Skipping rungs is a clinical decision, not a shortcut. Some people stay at a given concentration for longer than four weeks, that is not a failure; it is the prescriber matching the pace to the individual.

If you want a fuller picture of how long tirzepatide's effects last at each concentration level and what determines that duration, the duration of action page covers what the pharmacokinetics tell us about how long each weekly dose continues to work in your body.

How concentration affects what you see, and feel

At lower concentrations, most people notice appetite changes before they notice much else. Meals feel satisfying sooner. The urge to snack fades. Gastric emptying slows, which is why eating too quickly or too much at once can cause discomfort. As the concentration rises, those effects tend to deepen, and for most people the most noticeable gastrointestinal side effects (nausea, occasional loose stools, or constipation) become more prominent briefly after each step up before settling again.

None of that is a sign that the medicine has become dangerous. It is the expected pattern of a dose-escalating treatment. That said, side effects that are severe, persistent, or concern you should always be reported to your prescriber, and severe stomach pain that radiates toward the back warrants urgent medical attention, as the MHRA's guidance on GLP-1 medicines makes clear when discussing acute pancreatitis risk. You can report any suspected side effects directly via the MHRA's Yellow Card scheme.

Storage matters here too: the concentration you receive is only reliable if the pen has been kept correctly. Mounjaro pens should be refrigerated at 2–8°C; the precise room-temperature window is set out in the Patient Information Leaflet inside every box. For questions about what happens if a pen has been out of the fridge for longer than expected, the tirzepatide expiration page goes into the detail.

The concentration question your prescriber will ask at every review

Before any dose increase, a legitimate prescriber checks whether you have lost enough weight at the current concentration to justify moving up, and whether any side effects rule it out. At Mounjaro treatment through nume, every repeat order goes through a fresh clinical review, not a rubber stamp, but an actual read of your current weight and any concerns you have raised.

That review is why, when your pen arrives via DPD the next working day in plain, unmarked packaging, there is a prescription inside specific to your current concentration. The label is not incidental. It reflects a clinical decision made that day about what is right for you at this point in your treatment.

For anyone weighing up which treatment fits their situation, the weight-loss treatment overview sets out what is licensed in the UK and how the options compare. And if you have questions about how tirzepatide works beyond the concentration question, the tirzepatide information page covers the mechanism and evidence in detail.

If you are ready to talk through where you are in your treatment and whether your current concentration is still the right one, speaking to our prescribers is the straightforward next step.